XML 25 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Statutory Restrictions on Consolidated Stockholders' Equity and Investments
12 Months Ended
Dec. 31, 2017
Statutory Restrictions on Consolidated Stockholders' Equity and Investments [Abstract]  
Statutory Restrictions on Consolidated Stockholders' Equity and Investments
Statutory Accounting and Restrictions on Consolidated Stockholders’ Equity and Investments
The Consolidated Financial Statements have been prepared in conformity with GAAP, which differ in some respects from statutory accounting practices prescribed or permitted in the preparation of financial statements for submission to insurance regulatory authorities.
Combined capital and surplus on a statutory basis was $171,896,522 and $152,700,227 as of December 31, 2017 and 2016, respectively. Net income on a statutory basis was $18,766,527, $17,863,815 and $13,621,174 for the twelve months ended December 31, 2017, 2016 and 2015, respectively.
The Company has designated approximately $57,301,000 and $53,190,000 of retained earnings as of December 31, 2017 and 2016, respectively, as appropriated to reflect the required statutory premium and supplemental reserves. See Note 8 for the tax treatment of the statutory premium reserve.
As of December 31, 2017 and 2016, approximately $102,082,000 and $88,323,000, respectively, of consolidated stockholders’ equity represents net assets of the Company’s subsidiaries that cannot be transferred in the form of dividends, loans or advances to the parent company under statutory regulations without prior insurance department approval. During 2018, the maximum distributions the insurance subsidiaries can make to the Company without prior approval from applicable regulators total approximately $18,960,000.
Bonds totaling approximately $7,119,000 and $6,843,000 at December 31, 2017 and 2016, respectively, are deposited with the insurance departments of the states in which business is conducted.